# C_2015227EN.01000701.xml

| 11.7.2015 | EN | Official Journal of the European Union | C 227/7 |
| --- | --- | --- | --- |

11.7.2015

EN

Official Journal of the European Union

C 227/7

---

Prior notification of a concentration

(Case M.7662 — AXA Konzern/CompuGroup Medical Mobile/DTL)

(Text with EEA relevance)

(2015/C 227/07)

| 1. | On 2 July 2015, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking AXA Konzern Aktiengesellschaft (‘AXA’, Germany) controlled by AXA SA (France) and CompuGroup Medical Mobile GmbH (‘CompuGroup’, Germany) controlled by CompuGroup Medical Aktiengesellschaft (Germany) acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of a newly created joint venture (‘JV’, Germany) by way of purchase of shares. |
| --- | --- |

1.

On 2 July 2015, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking AXA Konzern Aktiengesellschaft (‘AXA’, Germany) controlled by AXA SA (France) and CompuGroup Medical Mobile GmbH (‘CompuGroup’, Germany) controlled by CompuGroup Medical Aktiengesellschaft (Germany) acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of a newly created joint venture (‘JV’, Germany) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | for AXA: provision of insurances and financial services, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for AXA: provision of insurances and financial services,

| — | for CompuGroup: supply of software for the healthcare sector, |
| --- | --- |

—

for CompuGroup: supply of software for the healthcare sector,

| — | the JV will be active in the development and supply of software for private health insurances. |
| --- | --- |

—

the JV will be active in the development and supply of software for private health insurances.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7662 — AXA Konzern/CompuGroup Medical Mobile/DTL, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7662 — AXA Konzern/CompuGroup Medical Mobile/DTL, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---